| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |